Routine

Vaginitis — bacterial vaginosis, vulvovaginal candidiasis & trichomoniasis

The three common causes of abnormal vaginal discharge; distinguished by history, pH and microscopy. BV and trichomoniasis in pregnancy carry obstetric risks. DRAFT for clinician review. · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Most abnormal vaginal discharge is due to one of three conditions. Bacterial vaginosis (BV): overgrowth of anaerobes (loss of lactobacilli), thin grey homogeneous discharge, fishy odour, raised vaginal pH (> 4.5), clue cells; not sexually transmitted but associated with preterm birth/late miscarriage in pregnancy. Vulvovaginal candidiasis (thrush): Candida albicans, thick white 'cottage-cheese' discharge, vulval itch/soreness, normal pH (<= 4.5); not an STI. Trichomoniasis: Trichomonas vaginalis (a sexually transmitted protozoan), frothy yellow-green offensive discharge, vulvovaginitis, 'strawberry cervix', raised pH; requires partner treatment and STI screen. Testing (pH, microscopy, NAAT for trichomonas) refines diagnosis when uncertain.

Red flags

  • Pregnancy with symptomatic BV/trichomoniasis (preterm birth/miscarriage association)
  • Recurrent candidiasis — screen for diabetes/immunosuppression/HIV
  • Trichomoniasis = confirmed STI — screen for coexisting STIs and offer HIV test
  • Pelvic pain, fever, cervical motion tenderness, deep dyspareunia = pelvic inflammatory disease (see PID entry)
  • Postmenopausal or postcoital/intermenstrual bleeding — exclude malignancy
  • Ulceration, severe vulval dermatosis, or not responding to treatment

Assessment

Differential diagnosis

  • Bacterial vaginosis
  • Vulvovaginal candidiasis
  • Trichomoniasis
  • Chlamydia/gonorrhoea cervicitis (mucopurulent discharge)
  • Physiological discharge
  • Atrophic vaginitis (postmenopausal)
  • Retained foreign body (tampon) / toxic shock
  • Dermatoses (lichen sclerosus/planus), contact dermatitis
  • Cervical/endometrial pathology if intermenstrual/postcoital bleeding

Investigations

  • Vaginal pH (narrow-range paper): BV and trichomoniasis > 4.5; candida usually <= 4.5
  • High vaginal swab / microscopy: BV clue cells (Amsel/Hay-Ison criteria), candida spores/pseudohyphae, motile trichomonads
  • NAAT for Trichomonas vaginalis (most sensitive); also test/treat for other STIs and offer full sexual health screen (HIV etc.) if trichomoniasis
  • Charcoal swab culture for recurrent/complicated candida (confirm species, e.g. non-albicans)
  • Consider endocervical NAAT for chlamydia/gonorrhoea if risk factors or cervicitis
  • In pregnancy: be alert to BV/trichomoniasis obstetric risk

Management

  • Take history (discharge character, odour, itch, sexual history, pregnancy, recurrence) and examine (speculum: discharge, cervix, vulva)
  • Use pH + microscopy/NAAT to distinguish the three; treat empirically if classic picture but confirm if uncertain or recurrent
  • Bacterial vaginosis: oral or vaginal metronidazole; avoid alcohol with oral metronidazole; treat if symptomatic or pregnant with risk factors (asymptomatic generally not treated outside pregnancy)
  • Candidiasis: antifungal (single-dose oral fluconazole or topical clotrimazole); in pregnancy use topical imidazole (avoid oral fluconazole)
  • Trichomoniasis: oral metronidazole; treat as an STI — partner notification/treatment, abstain until both treated, full STI screen
  • Address triggers for recurrent candida (diabetes, antibiotics, immunosuppression); consider maintenance regimen for recurrent (>= 4/year)
  • In pregnancy: manage BV/trichomoniasis per obstetric guidance; use pregnancy-safe agents
  • Advise avoidance of irritants/douching; provide written information and follow-up for recurrent/complicated cases

Drugs & doses

Bacterial vaginosis: Metronidazole 400 mg PO twice daily for 5-7 days (or 2 g PO single dose) — avoid alcohol; OR intravaginal metronidazole 0.75% gel once daily 5 days, OR clindamycin 2% cream 7 nights [verify local]
Vulvovaginal candidiasis: Fluconazole 150 mg PO single dose (NOT in pregnancy); OR clotrimazole 500 mg pessary stat +/- topical clotrimazole cream for vulval symptoms
Candidiasis in pregnancy: topical imidazole (clotrimazole pessary/cream) for up to 7 days; AVOID oral fluconazole in pregnancy
Recurrent candidiasis (>= 4/yr): induction fluconazole 150 mg every 72 h x3 then maintenance 150 mg weekly for 6 months [verify local]
Trichomoniasis: Metronidazole 400-500 mg PO twice daily for 5-7 days (or 2 g PO single dose); treat partner; avoid alcohol; metronidazole can be used in pregnancy (avoid high single dose) [verify local]
Non-albicans candida: topical boric acid 600 mg pessary nightly 14 days or nystatin — specialist/[verify local]

Disposition

Outpatient / primary care or sexual health clinic. Refer trichomoniasis (and partners) to genitourinary medicine for contact tracing and full STI screen. Pregnant women with symptomatic BV/trichomoniasis per obstetric pathway. Recurrent/complicated candidiasis to gynaecology/sexual health. Safety-net for PID features or failure to respond.

Complications & pitfalls

  • BV/trichomoniasis in pregnancy: preterm birth, late miscarriage, low birth weight, PPROM
  • Trichomoniasis: enhanced HIV transmission/acquisition
  • Recurrent/chronic candidiasis affecting quality of life
  • Ascending infection / PID (associated with BV)
  • Post-treatment relapse, partner reinfection (trichomoniasis)

Exam pearls

  • pH triages: raised pH (> 4.5) points to BV or trichomoniasis; normal pH with itch and cottage-cheese discharge is candida.
  • Trichomoniasis is an STI — treat the partner and do a full STI screen; candida and BV are not STIs.
  • Avoid oral fluconazole in pregnancy — use a topical imidazole.
  • Warn about the metronidazole-alcohol (disulfiram-like) reaction.
  • Treat symptomatic BV in pregnancy; it is linked to preterm birth.
  • Recurrent candida warrants a look for diabetes or immunosuppression (including HIV).

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.